Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)

被引:166
作者
Plante-Bordeneuve, V.
Ferreira, A.
Lalu, T.
Zaros, C.
Lacroix, C.
Adams, D.
Said, G.
机构
[1] Univ Paris Sud, Serv Neurol, Ctr Etude Neuropath Amyloides Familiales, Paris, France
[2] Univ Paris Sud, Hop Bicetre Assistance Publ Hop Paris, INSERM U788, Lab Ranvier, Paris, France
关键词
D O I
10.1212/01.wnl.0000267338.45673.f4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Transthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal dominant neuropathies of fatal outcome within 10 years after inaugural symptoms. Late diagnosis in patients who present as nonfamilial cases delays adequate management and genetic counseling. Clinical data of the 90 patients who presented as nonfamilial cases of the 300 patients of our cohort of patients with TTR-FAP were reviewed. They were 21 women and 69 men with a mean age at onset of 61 (extremes: 38 to 78 years) and 17 different mutations of the TTR gene including Val30Met (38 cases), Ser77Tyr (16 cases), lle107Val (15 cases), and Ser77Phe ( 5 cases). Initial manifestations included mainly limb paresthesias (49 patients) or pain (17 patients). Walking difficulty and weakness (five patients) and cardiac or gastrointestinal manifestations (five patients), were less common at onset. Mean interval to diagnosis was 4 years (range 1 to 10 years); 18 cases were mistaken for chronic inflammatory demyelinating polyneuropathy, which was the most common diagnostic error. At referral a length-dependent sensory loss affected the lower limbs in 2, all four limbs in 20, and four limbs and anterior trunk in 77 patients. All sensations were affected in 60 patients (67%), while small fiber dysfunction predominated in the others. Severe dysautonomia affected 80 patients (90%), with postural hypotension in 52, gastrointestinal dysfunction in 50, impotence in 58 of 69 men, and sphincter disturbance in 31. Twelve patients required a cardiac pacemaker. Nerve biopsy was diagnostic in 54 of 65 patients and salivary gland biopsy in 20 of 30. Decreased nerve conduction velocity, increased CSF protein, negative biopsy findings, and false immunolabeling of amyloid deposits were the main causes of diagnostic errors. We conclude that DNA testing, which is the most reliable test for TTR-FAP, should be performed in patients with a progressive length-dependent small fiber polyneuropathy of unknown origin, especially when associated with autonomic dysfunction.
引用
收藏
页码:693 / 698
页数:6
相关论文
共 17 条
[1]  
ADAMS D, 1992, REV NEUROL, V148, P736
[2]   The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation [J].
Adams, D ;
Samuel, D ;
Goulon-Goeau, C ;
Nakazato, M ;
Costa, PMP ;
Feray, C ;
Planté, V ;
Ducot, B ;
Ichai, P ;
Lacroix, C ;
Metral, S ;
Bismuth, H ;
Said, G .
BRAIN, 2000, 123 :1495-1504
[4]   POLYNEURITIC AMYLOIDOSIS IN A JAPANESE FAMILY [J].
ARAKI, S ;
MAWATARI, S ;
OHTA, M ;
NAKAJIMA, A ;
KUROIWA, Y .
ARCHIVES OF NEUROLOGY, 1968, 18 (06) :593-&
[5]   Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy [J].
Hattori, T ;
Takei, Y ;
Koyama, J ;
Nakazato, M ;
Ikeda, S .
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 (04) :229-239
[6]   GEOGRAPHICAL-DISTRIBUTION OF TTR MET(30) CARRIERS IN NORTHERN SWEDEN - DISCREPANCY BETWEEN CARRIER FREQUENCY AND PREVALENCE RATE [J].
HOLMGREN, G ;
COSTA, PMP ;
ANDERSSON, C ;
ASPLUND, K ;
STEEN, L ;
BEEKMAN, L ;
NYLANDER, PO ;
TEIXEIRA, A ;
SARAIVA, MJM ;
COSTA, PP .
JOURNAL OF MEDICAL GENETICS, 1994, 31 (05) :351-354
[7]   Familial transthyretin-type amyloid polyneuropathy in Japan - Clinical and genetic heterogeneity [J].
Ikeda, S ;
Nakazato, M ;
Ando, Y ;
Sobue, G .
NEUROLOGY, 2002, 58 (07) :1001-1007
[8]   Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan - Early-vs late-onset form [J].
Koike, H ;
Misu, K ;
Ikeda, S ;
Ando, Y ;
Nakazato, M ;
Ando, E ;
Yamamoto, M ;
Hattori, N ;
Sobue, G .
ARCHIVES OF NEUROLOGY, 2002, 59 (11) :1771-1776
[9]   Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. [J].
Lachmann, HJ ;
Booth, DR ;
Booth, SE ;
Bybee, A ;
Gilbertson, JA ;
Gillmore, JD ;
Pepys, MB ;
Hawkins, PN .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1786-1791
[10]   Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan - Clinicopathological and genetic features [J].
Misu, K ;
Hattori, N ;
Nagamatsu, M ;
Ikeda, S ;
Ando, Y ;
Nakazato, M ;
Takei, Y ;
Hanyu, N ;
Usui, Y ;
Tanaka, F ;
Harada, T ;
Inukai, A ;
Hashizume, Y ;
Sobue, G .
BRAIN, 1999, 122 :1951-1962